Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Each 10 ng/mL increase in 25(OH)D was associated with a 19% decrease in the likelihood of EVA (OR = 0.81, 95% CI: 0.70 to 0.94, P = 0.008).Compared with Q1, Q4 had a significantly lower risk (OR = 0.55, 95% CI: 0.40 to 0.76, P < 0.001), while Q2 and Q3 did not differ (both P > 0.05).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This study examined the relationship between serum 25-hydroxyvitamin D [25(OH)D] levels and EVA in young and middle-aged healthy adults.This cross-sectional study included 2047 eligible participants who underwent physical examinations at the Health Management Center of the Affiliated Hospital of Qingdao University between May 2023 and May 2025.

Source: Abstract.

Participants were categorized into EVA group (n = 687) and control group (n = 1360) based on brachial ankle pulse wave velocity (baPWV).

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association between serum 25-hydroxyvitamin D levels and Early Vascular Aging in young and middle-aged adults

Cross-sectional study · PLOS One · 2026

Original publication title

Association between serum 25-hydroxyvitamin D levels and Early Vascular Aging in young and middle-aged adults

Jinpeng Cong; Rui Hu; Jinyan Ren; Xinfeng Wang; Na Li; Ying Sun

© 2026 Cong et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This study suggests an inverse association between 25(OH)D levels and EVA, with a more pronounced association possibly observed in men and individuals with overweight/obesity, and further indicates a threshold at 17.9 ng/mL below which this inverse association is significantly enhanced.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity worldwide. Early vascular aging (EVA) is an independent predictor of cardiovascular risk in young and middle-aged adults. The plausible association between EVA and vitamin D warrants further investigation.

Source: Background

Abstract: What methods does the paper describe?

This study examined the relationship between serum 25-hydroxyvitamin D [25(OH)D] levels and EVA in young and middle-aged healthy adults.This cross-sectional study included 2047 eligible participants who underwent physical examinations at the Health Management Center of the Affiliated Hospital of Qingdao University between May 2023 and May 2025. Participants were categorized into EVA group (n = 687) and control group (n = 1360) based on brachial ankle pulse wave velocity (baPWV). Logistic regression and restricted cubic splines assessed the association between 25(OH)D and EVA, with an inflection point identified using two-piecewise linear regression.

Subgroup analyses and interaction tests were conducted by age, sex, blood collection month, smoking status, alcohol drinking status, hypertension, diabetes, and body mass index (BMI).

Source: Methods

Abstract: Results

The prevalence of EVA was 33.56%. Each 10 ng/mL increase in 25(OH)D was associated with a 19% decrease in the likelihood of EVA (OR = 0.81, 95% CI: 0.70 to 0.94, P = 0.008).Compared with Q1, Q4 had a significantly lower risk (OR = 0.55, 95% CI: 0.40 to 0.76, P < 0.001), while Q2 and Q3 did not differ (both P > 0.05). Restricted cubic spline analysis showed a nonlinear L-shaped association (P for non linearity = 0.015) with a threshold at 17.90 ng/mL: below this level, higher 25(OH)D was linked to a lower EVA risk (OR=0.90,95%CI: 0.85 to 0.96), whereas no significant association was observed above it.

Subgroup analyses indicated a particularly significant inverse association between 25(OH)D levels and EVA in men and overweight/obese individuals. Significant interactions were observed for sex, BMI, and age (all P < 0.05), while interactions with other factors, such as blood collection month, hypertension, diabetes, smoking status, drinking status were not statistically significant.

Source: Results

Abstract: Conclusion

This study suggests an inverse association between 25(OH)D levels and EVA, with a more pronounced association possibly observed in men and individuals with overweight/obesity, and further indicates a threshold at 17.9 ng/mL below which this inverse association is significantly enhanced.

Source: Conclusion
Authors’ abstract

Background

Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity worldwide. Early vascular aging (EVA) is an independent predictor of cardiovascular risk in young and middle-aged adults. The plausible association between EVA and vitamin D warrants further investigation.

Methods

This study examined the relationship between serum 25-hydroxyvitamin D [25(OH)D] levels and EVA in young and middle-aged healthy adults.This cross-sectional study included 2047 eligible participants who underwent physical examinations at the Health Management Center of the Affiliated Hospital of Qingdao University between May 2023 and May 2025. Participants were categorized into EVA group (n = 687) and control group (n = 1360) based on brachial ankle pulse wave velocity (baPWV). Logistic regression and restricted cubic splines assessed the association between 25(OH)D and EVA, with an inflection point identified using two-piecewise linear regression.

Subgroup analyses and interaction tests were conducted by age, sex, blood collection month, smoking status, alcohol drinking status, hypertension, diabetes, and body mass index (BMI).

Results

The prevalence of EVA was 33.56%. Each 10 ng/mL increase in 25(OH)D was associated with a 19% decrease in the likelihood of EVA (OR = 0.81, 95% CI: 0.70 to 0.94, P = 0.008).Compared with Q1, Q4 had a significantly lower risk (OR = 0.55, 95% CI: 0.40 to 0.76, P < 0.001), while Q2 and Q3 did not differ (both P > 0.05). Restricted cubic spline analysis showed a nonlinear L-shaped association (P for non linearity = 0.015) with a threshold at 17.90 ng/mL: below this level, higher 25(OH)D was linked to a lower EVA risk (OR=0.90,95%CI: 0.85 to 0.96), whereas no significant association was observed above it.

Subgroup analyses indicated a particularly significant inverse association between 25(OH)D levels and EVA in men and overweight/obese individuals. Significant interactions were observed for sex, BMI, and age (all P < 0.05), while interactions with other factors, such as blood collection month, hypertension, diabetes, smoking status, drinking status were not statistically significant.

Conclusion

This study suggests an inverse association between 25(OH)D levels and EVA, with a more pronounced association possibly observed in men and individuals with overweight/obesity, and further indicates a threshold at 17.9 ng/mL below which this inverse association is significantly enhanced.

Publication and source details

Original title: Association between serum 25-hydroxyvitamin D levels and Early Vascular Aging in young and middle-aged adults

Jinpeng Cong; Rui Hu; Jinyan Ren; Xinfeng Wang; Na Li; Ying Sun

PLOS One · 2026

Competing Interests: The authors have declared that no competing interests exist.

* E-mail: doctorhurui@163.com
© 2026 Cong et al2026Cong et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.The author(s) received no specific funding for this work.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T10:32:06.644684+00:00

DOI: 10.1371/journal.pone.0349409 · PMC13189320